Thermo Fisher Scientific (TMO) PT Raised to $715 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Thermo Fisher Scientific (TMO) PT Raised to $715 at Citi
October 28, 2021 5:47 AM EDTCiti analyst Patrick Donnelly raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $715.00 (from $700.00) while maintaining a Buy rating.... More
Thermo Fisher lifts annual forecast on boost from COVID-related sales
October 27, 2021 6:19 AM EDTBy Mrinalika Roy
(Reuters) -Thermo Fisher Scientific Inc on Wednesday reported better-than-expected quarterly profit and raised its full-year forecast for revenue as well as earnings, fuelled by strong COVID-19 related sales and recovery in its mainstay business.
Shares of the world's largest maker of scientific instruments rose nearly 3% to touch a record high of $625.99 after it also raised its outlook for next year.
Thermo Fisher makes and sells coronavirus tests and also provides raw materials and... More
Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.09
October 27, 2021 6:09 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.76, $1.09 better than the analyst estimate of $4.67. Revenue for the quarter came in at $9.33 billion versus the consensus estimate of $8.39 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2021 EPS of $23.37, versus the consensus of... More
Thermo Fisher set to benefit from demand for testing kits, vaccines
October 26, 2021 1:22 PM EDTBy Amruta Khandekar and Mrinalika Roy
(Reuters) - Thermo Fisher Scientific Inc's third-quarter profit is likely to get a boost from a rebound in COVID-19 testing due to the highly contagious Delta variant and sustained demand for vaccines against the coronavirus, Wall Street analysts said.
In July, when cases eased in the United States, the company cut its annual sales forecast for COVID-19 tests by $900 million. But the demand has again picked up pace in recent months amid a surge in Delta-led infections.
The world's largest maker of scientific instruments, which also supplies raw materials for COVID-19... More
